North East and North Cumbria
ICS Formulary
ICS Formulary
9 Nutrition and blood
09-01-04 Drugs used in autoimmune thrombocytopenic purpura
| Anagrelide |
|
Formulary
|
|
|
| Avatrombopag Doptelet® |
|
Formulary
|
|
 NICE TA626: Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure NICE TA853: Avatrombopag for treating primary chronic immune thrombocytopenia |
|
| Caplacizumab Cablivi® |
|
Formulary
|
|
|
NICE TA667: Caplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpura |
|
|
| Eltrombopag |
|
Formulary
|
|
|
NICE TA293: Eltrombopag for treating chronic ITP |
|
|
| Lusutrombopag |
|
Formulary
|
|
|
NICE TA617: Lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure |
|
|
| Romiplostim |
|
Formulary
|
|
|
NICE TA221: Thrombocytopenic purpura - romiplostim |
|
|
Links
NENC Guidelines for the recognition and management of non-IgE cow’s milk protein allergy (CMA) in infants- NICE NG203: Chronic kidney disease: assessment and management
- NICE TA1003 : Exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia in people 12 years and over
- NICE TA221: Thrombocytopenic purpura - romiplostim
- NICE TA293: Eltrombopag for treating chronic ITP
- NICE TA617: Lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure
- NICE TA626: Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure
- NICE TA667: Caplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpura
- NICE TA853: Avatrombopag for treating primary chronic immune thrombocytopenia